|
RAD23B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.23499999996157E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.55059999951135E-07 |
| Normal-vs-Stage2 |
9.234300E-02 |
| Normal-vs-Stage3 |
1.768380E-01 |
| Normal-vs-Stage4 |
9.975600E-01 |
| Stage1-vs-Stage2 |
2.626200E-01 |
| Stage1-vs-Stage3 |
6.305500E-02 |
| Stage1-vs-Stage4 |
1.774380E-01 |
| Stage2-vs-Stage3 |
6.699400E-01 |
| Stage2-vs-Stage4 |
3.662200E-01 |
| Stage3-vs-Stage4 |
4.940600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.36239999998433E-06 |
| Normal-vs-AfricanAmerican |
1.177680E-04 |
| Normal-vs-Asian |
3.686600E-01 |
| Caucasian-vs-AfricanAmerican |
7.573800E-01 |
| Caucasian-vs-Asian |
9.052400E-01 |
| AfricanAmerican-vs-Asian |
8.080400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.95920000223282E-08 |
| Normal-vs-Female |
3.768600E-01 |
| Male-vs-Female |
8.392100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.782300E-03 |
| Normal-vs-Extreme_Weight |
6.97869984023214E-10 |
| Normal-vs-Obese |
7.361500E-02 |
| Normal-vs-Extreme_Obese |
3.567800E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.221990E-01 |
| Normal_Weight-vs-Obese |
3.636400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.530000E-01 |
| Extreme_Weight-vs-Obese |
6.544600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.330800E-01 |
| Obese-vs-Extreme_Obese |
3.539200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.164600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.263590E-03 |
| Normal-vs-Age(61-80Yrs) |
3.0977999998516E-07 |
| Normal-vs-Age(81-100Yrs) |
9.93220000022887E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.702400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.686300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.168100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.588100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.114420E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.802440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.18289999596311E-09 |
| Normal-VS-Type2 PRCC |
9.502300E-03 |
| Normal-VS-KIRP CIMP |
5.441800E-02 |
| Normal-VS-Unclassified PRCC |
1.846410E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.778100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.239500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.358760E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.797800E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
9.395800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.643500E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.61269999999969E-05 |
| Normal-vs-N1 |
6.482600E-01 |
| Normal-vs-N2 |
9.308600E-01 |
| N0-vs-N1 |
1.002240E-02 |
| N0-vs-N2 |
4.790600E-01 |
| N1-vs-N2 |
9.588200E-01 |
|
|
